Pfizer, founded in 1849, is one of the world's leading biopharmaceutical companies with a history of 160 years. Pfizer's corporate strategy is to explore, develop, produce and promote high-quality, safe and efficient prescription drugs to provide healthy lives for humans and animals; At the same time, it has established extensive partnerships with health care providers, governments and local communities around the world to further expand its drug coverage and provide better health care and health system support. This strategy can be seen from several specific actions of Pfizer: First, sell Pfizer's own personal consumption inspection business in order to concentrate on prescription drug business. As early as June 2006, Johnson & Johnson invested $654.38+066 billion to acquire the personal consumer health care business in Pfizer. Pfizer's personal consumer health care business includes personal consumer goods and some over-the-counter drugs. Well-known brands such as Bengay painkiller, Listerine mouthwash, Sudafed cold medicine and Vi-sine eye drops owned by Pfizer were all included in Johnson & Johnson's bag. Pfizer divested its personal consumer health care business, mainly because the company is concentrating on developing its main business-prescription drugs. At present, the best-selling products of this pharmaceutical company are Lipitor, oral antifungal agent Dafukang, antibiotic histamine, Viagra for the treatment of ED, etc. Based on the success of these professional prescription drugs, Pfizer not only established its position as a world-class pharmaceutical company, but also became the largest multinational pharmaceutical company by acquiring Wyeth, a pharmaceutical company also ranked among the top 500 in the world. Looking at Pfizer's global strategy, it is obvious that Pfizer values being close to the people and being professional. At present, Pfizer has branches in more than 90 countries. In China, for example, Pfizer China has nearly 4,000 employees and conducts business activities in more than 65,438+000 cities nationwide. It has four first-class production facilities in Dalian, Suzhou and Wuxi, and a management center in Beijing. At the same time, it has its own independent large-scale R&D center in Shanghai. Since its establishment in 2005, it has cooperated with top academic research institutions in China, including Peking University, Tsinghua University, Shanghai Jiaotong University and relevant branches of Chinese Academy of Sciences, with a high degree of international cooperation and integration. At the same time, the cooperation with China is also very close.